Curis Inc (CRIS)
15.85
-0.47
(-2.88%)
USD |
NASDAQ |
May 10, 16:00
15.85
0.00 (0.00%)
After-Hours: 20:00
Curis Profit Margin (Quarterly): -434.4% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -434.4% |
| September 30, 2023 | -430.0% |
| June 30, 2023 | -544.4% |
| March 31, 2023 | -503.2% |
| December 31, 2022 | -392.4% |
| September 30, 2022 | -470.6% |
| June 30, 2022 | -666.1% |
| March 31, 2022 | -783.1% |
| December 31, 2021 | -434.4% |
| September 30, 2021 | -363.6% |
| June 30, 2021 | -474.1% |
| March 31, 2021 | -453.5% |
| December 31, 2020 | -248.6% |
| September 30, 2020 | -217.9% |
| June 30, 2020 | -284.2% |
| March 31, 2020 | -358.4% |
| December 31, 2019 | -261.9% |
| September 30, 2019 | -225.4% |
| June 30, 2019 | -344.5% |
| March 31, 2019 | -559.4% |
| December 31, 2018 | -215.6% |
| September 30, 2018 | -253.7% |
| June 30, 2018 | -367.4% |
| March 31, 2018 | -435.5% |
| December 31, 2017 | -246.1% |
| Date | Value |
|---|---|
| September 30, 2017 | -632.4% |
| June 30, 2017 | -683.6% |
| March 31, 2017 | -738.7% |
| December 31, 2016 | -479.8% |
| September 30, 2016 | -1.61K% |
| June 30, 2016 | -672.0% |
| March 31, 2016 | -547.0% |
| December 31, 2015 | -643.5% |
| September 30, 2015 | -271.1% |
| June 30, 2015 | -390.2% |
| March 31, 2015 | -1.92K% |
| December 31, 2014 | -285.6% |
| September 30, 2014 | -316.2% |
| June 30, 2014 | -39.48% |
| March 31, 2014 | -433.1% |
| December 31, 2013 | -275.4% |
| September 30, 2013 | -25.93% |
| June 30, 2013 | -23.94% |
| March 31, 2013 | -569.4% |
| December 31, 2012 | -733.6% |
| September 30, 2012 | -585.9% |
| June 30, 2012 | -66.33% |
| March 31, 2012 | 21.49% |
| December 31, 2011 | 43.03% |
| September 30, 2011 | -2.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-783.1%
Minimum
Mar 2022
-217.9%
Maximum
Sep 2020
-415.3%
Average
-430.0%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Electromed Inc | 12.23% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -149.4% |
| Return on Assets | -52.11% |
| Return on Invested Capital | -149.4% |
| Gross Profit Margin (Quarterly) | 98.00% |
| Operating Margin (Quarterly) | -452.5% |
| Return on Net Operating Assets | -297.4% |